Citius Pharmaceuticals Inc (CTXR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-2024 | 09-2023 | 09-2022 | 09-2021 | 09-2020 | |
| Operating Expenses | 41,996 | 36,732 | 33,316 | 23,532 | 17,711 |
| Operating Income | -41,996 | -36,732 | -33,316 | -23,532 | -17,711 |
| Interest Expense | 0 | 0 | 0 | 11 | 16 |
| Other Income | 3,146 | 4,765 | 251 | 488 | 178 |
| Pre-tax Income | -38,850 | -31,967 | -33,065 | -23,054 | -17,548 |
| Income Tax | 576 | 576 | 576 | N/A | N/A |
| Net Income Continuous | -39,426 | -32,543 | -33,641 | -23,054 | -17,548 |
| Minority Interests | -287 | N/A | N/A | N/A | N/A |
| Net Income | $-39,139 | $-32,543 | $-33,641 | $-23,054 | $-17,548 |
| EPS Basic Total Ops | -5.97 | -5.57 | -5.75 | -5.75 | -11.25 |
| EPS Basic Continuous Ops | -5.86 | -5.38 | -5.76 | -5.31 | -11.20 |
| EPS Diluted Total Ops | -5.97 | -5.57 | -5.75 | -5.75 | -11.25 |
| EPS Diluted Continuous Ops | -5.86 | -5.38 | -5.76 | -5.31 | -11.20 |
| EPS Diluted Before Non-Recurring Items | -5.97 | -6.00 | -5.75 | -5.75 | -11.25 |
| EBITDA(a) | $-41,786 | $-36,538 | $-33,136 | $-23,367 | $-17,558 |